Global Cytogenetics Markets, Technology, & Competitive Landscape Report 2021 with Profiles of 70 Companies - ResearchAndMarkets.com
Retrieved on:
Thursday, November 18, 2021
Technology, Biotechnology, Nanotechnology, Health, CGH, Chromosome, Fort Dix, Single-nucleotide polymorphism, Optical flow, Technology, Magnetic resonance imaging, Biomarker, FISH, PCR, Diagnosis, Disease, SWOT, Nanotechnology, Cancer, SPM, AFM, Human, Fluorescence, Therapy, PNA, Genetic variation, Molecular imaging, Lists of diseases, Hybridization probe, DNA, Organic acid, Infection, MRI, Optical mapping, PET, In situ hybridization, Drug discovery, Company, Genetic disorder, Real-time polymerase chain reaction, Comparative genomic hybridization, Pharmaceutical industry, Medical imaging, Microscope
This report deals with cytogenetics in a broader sense rather than the classical use mainly to describe the chromosome structure and identify abnormalities related to disease.
Key Points:
- This report deals with cytogenetics in a broader sense rather than the classical use mainly to describe the chromosome structure and identify abnormalities related to disease.
- The scope of cytogenetics includes several technologies besides fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and multicolor FISH.
- Molecular cytogenetics includes the applications of nanobiotechnology, microarrays, real-time polymerase chain reaction (PCR), in vivo imaging, and single molecule detection.
- The report includes summary profiles of 70 companies relevant to cytogenetics along with their 80 collaborations.